Harnessing the power of synthetic biology, protein engineering and cell-protective physiology
General Biologics, Inc. uses the power of rational biological design to create new classes of therapeutics for treatment of unmet medical needs that have been underserved by the research community and overlooked by investors.
We have used this approach to develop a ground-breaking, first-in-class fusion protein therapeutic for treatment of hypoxia.
Synthetic biologists have proposed that biological systems can be rationally designed from well understood living components. General Biologics has adapted this approach to create novel therapeutics, using three-dimensional modeling of protein structures to integrate protein design with cell biology and signal transduction physiology.